drugset / Trial / NCT01698931
Efficacy of Repaglinide in Subjects With Type 2 Diabetes
RandomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to compare the efficacy of repaglinide to glyburide and placebo on hepatic glucose metabolism in subjects with type 2 diabetes.
Timeline
- Start
- 2002-04-26
- Primary completion
- 2003-03-06
- Completion
- 2003-03-06
Publications
- Results Ciccarone A, Mari A, Pulizzi N, Bianchi C, Palumbo F, Benzi L, Del Prato S. Assessment of insulin secretion in response to a mixed meal in type 2 diabetes. Effects of short-term repaglinide and glibenclamide administration. Diabetologia 2005; 48 (Suppl. 1): A284 (Abstract No. PS65-781)
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glyburide | Small molecule | 5 mg | — |
| Subject | Repaglinide | Small molecule | 1 mg | — |